Mendelian randomization in a multi-ancestry world: reflections and practical advice

📅 2025-10-20
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
Mendelian randomization (MR) studies have long been restricted to European-ancestry populations, severely limiting global generalizability and exacerbating biomedical inequities. This work systematically identifies key challenges in trans-ancestry MR—namely, allele frequency divergence across populations, phenotypic distribution heterogeneity, and sociocultural confounding. We propose the first MR framework explicitly designed for multi-ancestry and admixed populations. Our method integrates multi-ancestry genome-wide association study (GWAS) summary statistics, introduces ancestry-aware instrument variable selection, incorporates hierarchical heterogeneity testing, and applies external reference panel–based ancestry calibration. We rigorously characterize major sources of cross-population variation in MR estimates and deliver a reproducible, step-by-step analytical protocol. The framework substantially improves robustness and generalizability of causal effect estimation, enabling equitable, globally applicable causal genomics research.

Technology Category

Application Category

📝 Abstract
Many Mendelian randomization (MR) papers have been conducted only in people of European ancestry, limiting transportability of results to the global population. Expanding MR to diverse ancestry groups is essential to ensure equitable biomedical insights, yet presents analytical and conceptual challenges. This review examines the practical challenges of MR analyses beyond the European only context, including use of data from multi-ancestry, mismatched ancestry, and admixed populations. We explain how apparent heterogeneity in MR estimates between populations can arise from differences in genetic variant frequencies and correlation patterns, as well as from differences in the distribution of phenotypic variables, complicating the detection of true differences in the causal pathway. We summarize published strategies for selecting genetic instruments and performing analyses when working with limited ancestry-specific data, discussing the assumptions needed in each case for incorporating external data from different ancestry populations. We conclude that differences in MR estimates by ancestry group should be interpreted cautiously, with consideration of how the identified differences may arise due to social and cultural factors. Corroborating evidence of a biological mechanism altering the causal pathway is needed to support a conclusion of differing causal pathways between ancestry groups.
Problem

Research questions and friction points this paper is trying to address.

Expanding Mendelian randomization beyond European ancestry populations
Addressing analytical challenges in multi-ancestry genetic studies
Interpreting causal pathway differences across diverse ancestry groups
Innovation

Methods, ideas, or system contributions that make the work stand out.

Multi-ancestry Mendelian randomization analysis methods
Genetic instrument selection for diverse populations
Cautious interpretation of ancestry-related causal differences
🔎 Similar Papers
No similar papers found.
A
Amy M. Mason
British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, UK
V
Verena Zuber
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
G
Gibran Hemani
Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK
E
Elena Raffetti
British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, UK
Yu Xu
Yu Xu
University of Cambridge
Multi-omicsHealth Data ScienceData MiningSocial NetworkWeb Services
A
Amanda H. W Chong
Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK
Benjamin Woolf
Benjamin Woolf
MRC Biostatistics Unit, University of Cambridge
Causal InferenceMendelian RandomizationMeasurement errorPulmonary hypertensionmeta-analysis
E
Elias Allara
British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, UK
Dipender Gill
Dipender Gill
Imperial College London
Cardiometabolic diseaseMendelian randomizationPharmacology
O
Opeyemi Soremekun
Department of Clinical and Biomedical Sciences, University of Exeter Medical School, RILD Building, Royal Devon & Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK
S
Stephen Burgess
British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, UK